Antidiabetic Medications and Insulin Management

Antihyperglycemic Medications for Type 2 Diabetes

For patients with Type 2 diabetes, various drug classes target different physiological mechanisms to lower blood glucose.

First-Line and Secretagogues

• Biguanides (Metformin): The preferred first-line therapy. It improves glucose regulation by decreasing hepatic glucose production without stimulating insulin secretion, which lowers the risk of hypoglycemia. However, clinicians must monitor renal function closely.
• Sulfonylureas & Meglitinides: These are "secretagogues" that stimulate the pancreas to release more insulin. While effective, they carry a significantly higher risk of hypoglycemia.

Sensitivity and Absorption Modifiers

• Thiazolidinediones (TZDs): These improve insulin sensitivity in peripheral tissues but are associated with potential weight gain.
• Alpha-glucosidase Inhibitors (Acarbose): These work in the gut to delay the absorption of carbohydrates. To be effective, they must be taken with the very first bite of a meal.

Incretin-Based Therapies and SGLT2 Inhibitors

• DPP-4 Inhibitors: These slow the breakdown of incretin hormones, helping to manage post-meal glucose.
• GLP-1 Receptor Agonists: These incretin mimetics increase insulin secretion and slow gastric emptying, which often results in beneficial weight loss.
• GIP/GLP-1 Receptor Agonists: Newer dual-agonist therapies that further enhance metabolic regulation.
• SGLT2 Inhibitors: These promote the excretion of glucose through the urine. While they offer cardiovascular and renal benefits, they increase the risk of genitourinary infections and volume depletion (dehydration).

Clinical Management and Nursing Implications

Safety and Administration

Insulin is classified as a high-alert medication. This means it carries a high risk of causing significant harm if used incorrectly. Nurses must perform independent double-checks with another licensed professional to verify the dose, type, and timing before administration.

Exam Tip: When a patient is NPO (nothing by mouth), do not simply stop all insulin. Basal insulin is often continued at a reduced dose to prevent ketoacidosis, but prandial (mealtime) doses are typically held because there is no incoming glucose to manage.

Managing Hypoglycemia and Hyperglycemia

Nurses must be vigilant in recognizing the signs of glucose fluctuations:

• Hypoglycemia (Low Blood Sugar): Often presents with shakiness, sweating, confusion, or tachycardia.
  • Mild cases: Treat with 15g of fast-acting glucose (e.g., juice, glucose tabs).
  • Severe cases: May require glucagon or IV dextrose.
• Hyperglycemia (High Blood Sugar): Can lead to dehydration and long-term vascular damage.

Sick-Day Management

During illness, physiological stress can cause glucose levels to fluctuate wildly. Patients should be educated on a "sick-day plan," which includes frequent glucose monitoring, maintaining hydration, and knowing when to contact their provider.

Critical Nursing Connections

Nurses must consider how other medications interact with diabetes management. For example, Beta-blockers can mask the sympathetic symptoms of hypoglycemia (like tachycardia), making it harder for a patient to realize their blood sugar is dropping. Additionally, both Salbutamol (a beta-2 agonist) and Insulin can cause a shift of potassium into the cells, necessitating close monitoring of serum potassium levels.